Financhill
Sell
39

STRR Quote, Financials, Valuation and Earnings

Last price:
$2.26
Seasonality move :
-1.34%
Day range:
$2.26 - $2.50
52-week range:
$1.72 - $5.35
Dividend yield:
0%
P/E ratio:
0.75x
P/S ratio:
0.13x
P/B ratio:
0.22x
Volume:
23.3K
Avg. volume:
20.6K
1-year change:
-46.67%
Market cap:
$7.5M
Revenue:
$53.4M
EPS (TTM):
-$3.58

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
STRR
Star Equity Holdings
$16.4M -$0.25 18.67% -43.28% $8.50
CTSO
CytoSorbents
$9M -$0.07 12.94% -41.38% $5.00
DCTH
Delcath Systems
$16.8M $0.03 179.13% -93.78% $23.00
EXAS
Exact Sciences
$688.6M -$0.10 10.52% -84.17% $68.83
ILMN
Illumina
$1B $0.94 -5.72% 430.2% $106.60
NTRA
Natera
$446.7M -$0.66 15.16% -106.89% $191.91
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
STRR
Star Equity Holdings
$2.35 $8.50 $7.5M 0.75x $0.00 0% 0.13x
CTSO
CytoSorbents
$0.85 $5.00 $53.2M -- $0.00 0% 1.35x
DCTH
Delcath Systems
$18.10 $23.00 $630.4M -- $0.00 0% 11.11x
EXAS
Exact Sciences
$56.94 $68.83 $10.7B -- $0.00 0% 3.73x
ILMN
Illumina
$82.95 $106.60 $13.1B -- $0.00 0% 3.05x
NTRA
Natera
$153.27 $191.91 $20.9B -- $0.00 0% 10.73x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
STRR
Star Equity Holdings
18.39% -0.314 40.48% 0.69x
CTSO
CytoSorbents
49.38% 1.160 22.69% 1.98x
DCTH
Delcath Systems
-- 2.997 -- 13.86x
EXAS
Exact Sciences
49.21% 0.148 28.45% 2.12x
ILMN
Illumina
45.66% 0.950 15.77% 1.34x
NTRA
Natera
6.09% 3.386 0.42% 3.58x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
STRR
Star Equity Holdings
$3.1M -$2.8M -13.58% -15.99% -22.03% $200K
CTSO
CytoSorbents
$6.2M -$3.9M -58.93% -106.57% -10.01% -$3.5M
DCTH
Delcath Systems
$16.9M $642K -37.34% -40.28% 3.25% $2.1M
EXAS
Exact Sciences
$500.5M -$89.8M -19.08% -35.57% -13.04% -$365K
ILMN
Illumina
$683M $164M -20.34% -34.38% 19.89% $201M
NTRA
Natera
$316.8M -$79.2M -15.3% -19.19% -13.1% $22.6M

Star Equity Holdings vs. Competitors

  • Which has Higher Returns STRR or CTSO?

    CytoSorbents has a net margin of -9.1% compared to Star Equity Holdings's net margin of -16.94%. Star Equity Holdings's return on equity of -15.99% beat CytoSorbents's return on equity of -106.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    CTSO
    CytoSorbents
    71.13% -$0.02 $28.7M
  • What do Analysts Say About STRR or CTSO?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 262.27%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 488.17%. Given that CytoSorbents has higher upside potential than Star Equity Holdings, analysts believe CytoSorbents is more attractive than Star Equity Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    CTSO
    CytoSorbents
    1 1 0
  • Is STRR or CTSO More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison CytoSorbents has a beta of 1.171, suggesting its more volatile than the S&P 500 by 17.12%.

  • Which is a Better Dividend Stock STRR or CTSO?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or CTSO?

    Star Equity Holdings quarterly revenues are $12.9M, which are larger than CytoSorbents quarterly revenues of $8.7M. Star Equity Holdings's net income of -$1.2M is higher than CytoSorbents's net income of -$1.5M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.13x versus 1.35x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.13x 0.75x $12.9M -$1.2M
    CTSO
    CytoSorbents
    1.35x -- $8.7M -$1.5M
  • Which has Higher Returns STRR or DCTH?

    Delcath Systems has a net margin of -9.1% compared to Star Equity Holdings's net margin of 5.4%. Star Equity Holdings's return on equity of -15.99% beat Delcath Systems's return on equity of -40.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    DCTH
    Delcath Systems
    85.62% $0.03 $80.2M
  • What do Analysts Say About STRR or DCTH?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 262.27%. On the other hand Delcath Systems has an analysts' consensus of $23.00 which suggests that it could grow by 27.99%. Given that Star Equity Holdings has higher upside potential than Delcath Systems, analysts believe Star Equity Holdings is more attractive than Delcath Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    DCTH
    Delcath Systems
    4 0 0
  • Is STRR or DCTH More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Delcath Systems has a beta of 0.722, suggesting its less volatile than the S&P 500 by 27.805%.

  • Which is a Better Dividend Stock STRR or DCTH?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or DCTH?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Delcath Systems quarterly revenues of $19.8M. Star Equity Holdings's net income of -$1.2M is lower than Delcath Systems's net income of $1.1M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.13x versus 11.11x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.13x 0.75x $12.9M -$1.2M
    DCTH
    Delcath Systems
    11.11x -- $19.8M $1.1M
  • Which has Higher Returns STRR or EXAS?

    Exact Sciences has a net margin of -9.1% compared to Star Equity Holdings's net margin of -14.32%. Star Equity Holdings's return on equity of -15.99% beat Exact Sciences's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    EXAS
    Exact Sciences
    70.82% -$0.54 $4.7B
  • What do Analysts Say About STRR or EXAS?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 262.27%. On the other hand Exact Sciences has an analysts' consensus of $68.83 which suggests that it could grow by 20.89%. Given that Star Equity Holdings has higher upside potential than Exact Sciences, analysts believe Star Equity Holdings is more attractive than Exact Sciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    EXAS
    Exact Sciences
    18 3 0
  • Is STRR or EXAS More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Exact Sciences has a beta of 0.920, suggesting its less volatile than the S&P 500 by 7.968%.

  • Which is a Better Dividend Stock STRR or EXAS?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or EXAS?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Exact Sciences quarterly revenues of $706.8M. Star Equity Holdings's net income of -$1.2M is higher than Exact Sciences's net income of -$101.2M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.13x versus 3.73x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.13x 0.75x $12.9M -$1.2M
    EXAS
    Exact Sciences
    3.73x -- $706.8M -$101.2M
  • Which has Higher Returns STRR or ILMN?

    Illumina has a net margin of -9.1% compared to Star Equity Holdings's net margin of 12.58%. Star Equity Holdings's return on equity of -15.99% beat Illumina's return on equity of -34.38%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    ILMN
    Illumina
    65.61% $0.82 $4.4B
  • What do Analysts Say About STRR or ILMN?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 262.27%. On the other hand Illumina has an analysts' consensus of $106.60 which suggests that it could grow by 28.51%. Given that Star Equity Holdings has higher upside potential than Illumina, analysts believe Star Equity Holdings is more attractive than Illumina.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    ILMN
    Illumina
    6 11 0
  • Is STRR or ILMN More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Illumina has a beta of 1.349, suggesting its more volatile than the S&P 500 by 34.945%.

  • Which is a Better Dividend Stock STRR or ILMN?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Illumina pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or ILMN?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Illumina quarterly revenues of $1B. Star Equity Holdings's net income of -$1.2M is lower than Illumina's net income of $131M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Illumina's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.13x versus 3.05x for Illumina. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.13x 0.75x $12.9M -$1.2M
    ILMN
    Illumina
    3.05x -- $1B $131M
  • Which has Higher Returns STRR or NTRA?

    Natera has a net margin of -9.1% compared to Star Equity Holdings's net margin of -13.34%. Star Equity Holdings's return on equity of -15.99% beat Natera's return on equity of -19.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    STRR
    Star Equity Holdings
    24.27% -$0.52 $73.2M
    NTRA
    Natera
    63.12% -$0.50 $1.3B
  • What do Analysts Say About STRR or NTRA?

    Star Equity Holdings has a consensus price target of $8.50, signalling upside risk potential of 262.27%. On the other hand Natera has an analysts' consensus of $191.91 which suggests that it could grow by 25.21%. Given that Star Equity Holdings has higher upside potential than Natera, analysts believe Star Equity Holdings is more attractive than Natera.

    Company Buy Ratings Hold Ratings Sell Ratings
    STRR
    Star Equity Holdings
    1 0 0
    NTRA
    Natera
    12 0 0
  • Is STRR or NTRA More Risky?

    Star Equity Holdings has a beta of 0.871, which suggesting that the stock is 12.92% less volatile than S&P 500. In comparison Natera has a beta of 1.794, suggesting its more volatile than the S&P 500 by 79.445%.

  • Which is a Better Dividend Stock STRR or NTRA?

    Star Equity Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Star Equity Holdings pays -19.54% of its earnings as a dividend. Natera pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios STRR or NTRA?

    Star Equity Holdings quarterly revenues are $12.9M, which are smaller than Natera quarterly revenues of $501.8M. Star Equity Holdings's net income of -$1.2M is higher than Natera's net income of -$66.9M. Notably, Star Equity Holdings's price-to-earnings ratio is 0.75x while Natera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Star Equity Holdings is 0.13x versus 10.73x for Natera. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STRR
    Star Equity Holdings
    0.13x 0.75x $12.9M -$1.2M
    NTRA
    Natera
    10.73x -- $501.8M -$66.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Why Mobileye Might Be Wall Street’s Next Big Surprise
Why Mobileye Might Be Wall Street’s Next Big Surprise

The trend to automate vehicles started long ago when adding…

Why Is Rigetti Stock Going Up?
Why Is Rigetti Stock Going Up?

Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
99
SOC alert for May 20

Sable Offshore [SOC] is down 0.79% over the past day.

Buy
52
RGC alert for May 20

Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.

Sell
40
GWLIF alert for May 20

Great-West Lifeco [GWLIF] is up 13.42% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock